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Abstract: AIMS To compare the radiographic marginal bone levels of implants placed in sites previ-
ously augmented with autogenous bone grafts and implants placed in native bone. Secondary outcomes
included: implant survival, periodontal/peri-implant parameters as well as short- and long-term patient-
reported outcome measures. MATERIALS AND METHODS The study was designed as a case-control
study including 38 patients equally distributed into two groups (previously augmented with autogenous
bone blocks [AB] and implants placed in native bone [NB]). In total, 67 implants were placed. Clinical,
radiographic and patient-reported outcome measures (PROMs), and complication rates were assessed
based on a chart review and at a follow-up examination (฀5 years after implant placement). Nonpara-
metric mixed models were applied for the comparison of the two groups because of the clustered data.
The data were analyzed descriptively, and p-values were calculated using nonparametric mixed models
to account for the clustered data. RESULTS The mean follow-up time was 10.2 years (range 6-13 years;
AB) and 8.3 years (range 5-16 years; NB). One implant was lost in group NB (97.5% survival rate) and
none in group AB (100%). Following primary augmentation, six major complications (wound dehiscences,
acute pulpitis, intra- and extraoral sensitivity disturbances) were observed at the donor sites. At time
of implant placement, only minimal complications occurred and only in group NB. Median marginal
bone levels at the follow-up were significantly higher in group NB (1.15; Q1: 0.50 mm/Q3: 1.83 mm)
than in group AB (1.58; Q1: 1.01 mm/Q3: 2.40 mm; p = 0.0411). Probing depth, bleeding on prob-
ing and recession values were similar in both groups. PROMs revealed high visual analog scale values
(i.e., high satisfaction) for both procedures. CONCLUSIONS Dental implants placed in sites augmented
with autogenous bone or in native bone revealed healthy peri-implant tissues after 5-16 years. Marginal
bone levels were significantly higher for implant placed in native bone. Complications following primary
augmentation encompassed every third patient but were mostly transient.
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Aims: to compare the radiographic marginal bone levels of implants placed in sites previously 
augmented with autogenous bone grafts and implants placed in native bone. Secondary outcomes 
included: implant survival, periodontal/peri-implant parameters as well as short- and long-term 
patient-reported outcome measures.  
Materials and methods: The study was designed as a case-control study including 38 patients 
equally distributed into two groups (previously augmented with autogenous bone blocks (AB) and 
implants placed in native bone (NB)). In total 67 implants were placed. Clinical, radiographic and 
patient-reported outcome measures (PROMs) as well as complication rates were assessed based 
on a chart review and at a follow-up examination (≧5 years after implant placement). 
Nonparametric mixed models were applied for the comparison of the two groups because of the 
clustered data. The data was analyzed descriptively, and p-values were calculated using 
nonparametric mixed models to account for the clustered data. 
Results: The mean follow-up time was 10.2 years (range 6-13 years; AB) and 8.3 years (range 
5-16 years; NB). One implant was lost in group NB (97.5% survival rate) and none in group AB 
(100%). Following primary augmentation, six major complications (wound dehiscences, acute 
pulpitis, intra- and extraoral sensitivity disturbances) were observed at the donor sites. At time of 
implant placement, only minimal complications occurred and only in group NB. Median marginal 
bone levels at the follow-up were significantly higher in group NB (1.15; Q1: 0.50 mm/Q3: 1.83 
mm) than in group AB (1.58; Q1: 1.01 mm/Q3: 2.40 mm; p=0.0411). Probing depth, bleeding on 
probing and recession values were similar in both groups. PROMs revealed high visual analogue 
scale values (i.e. high satisfaction) for both procedures. 
Conclusions: Dental implants placed in sites augmented with autogenous bone or in native bone 
revealed healthy peri-implant tissues after 5-16 years. Marginal bone levels were significantly 
higher for implant placed in native bone. Complications following primary augmentation 
encompassed every third patient but were mostly transient.  
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Introduction 
Dental implants demonstrate predictable long-term outcomes with high survival rates when placed 
in sufficient bone volume with an adequate bone quality (Adell et al., 1981, Pylant et al., 1992, 
Jemt and Lekholm, 1993, Weber et al., 2000). Due to the successful use of dental implants, 
treatment options have expanded over the years, starting as anchors for fixed reconstructions in 
fully edentulous cases to single implants supporting crowns in the esthetic zone.  
Clinically, a prosthetically-driven implant planning may result in a prospective implant location that 
does not present a sufficient bone volume to place a dental implant. This is due to an atrophy of 
hard and soft tissues following tooth loss (Amler et al., 1960, Pietrokovski and Massler, 1967). In 
case the amount of bone volume is not sufficient to achieve primary implant stability, various 
options exist to augment bone at the desired site prior to implant placement (Raghoebar et al., 
2007). Among the methods described in the literature, the use of autogenous bone blocks is 
considered as gold standard (Stern and Barzani, 2015). 
Autogenous bone grafts provide an excellent biologic compatibility, are predictable and render 
sufficient bone quality and quantity to place dental implants (Raghoebar et al., 2007, Von Arx and 
Buser, 2006). Extra- and intraoral donor sites may be considered to harvest the desired bone 
grafts. Extraoral donor sites necessitate extensive surgery and hospitalization of the patient 
increasing the costs of the treatment and the morbidity of the patient (Marx and Morales, 1988). 
If the volume of the required bone is not larger than a three-teeth segment, intraoral sites may 
be preferred over extraoral sites (Raghoebar et al., 2007). As intraoral donor sites, the chin region, 
the posterior regions of the mandible or the tuberositas in the maxilla may be considered (Zeltner 
et al., 2016). The closer the donor and recipient sites are, the shorter is the opening flap, the 
surgery and anesthesia time (Misch, 1997). The access to harvest a chin bone graft was reported 
to be easily accessible and convenient, the type and quality of bone obtainable to be sufficient, 
and the risk-benefit ratio to be excellent (Raghoebar et al., 2007). Due to that, the harvesting of 
chin bone has been extensively described in the literature (Hoppenreijs et al., 1992, Misch et al., 
1992, Weibull et al., 2009, Nkenke et al., 2001). In contrast, bone harvested from the retromolar 
area shows less morbidity (Raghoebar et al., 2007). A couple of disadvantages and limitations 
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reported as patient morbidity at the donor site were described. This included: i) altered sensation, 
ii) sensory disturbance, iii) pain, iv) sensitivity loss of the lower anterior teeth and, v) recipient 
site morbidity such as resorption of the graft and intra-oral scarring (Weibull et al., 2009, Nkenke 
et al., 2001, Raghoebar et al., 2001, Clavero and Lundgren, 2003, Joshi, 2004). 
While the efficacy of autogenous bone grafting procedures has been comprehensively described in 
the literature, only few data are available reporting on the long-term morbidity and on the long-
term outcome of implants placed into previously augmented bone grafts. 
The aims of the present study were i) to compare the long-term survival and clinical performance 
of implants placed in sites previously augmented with autogenous bone grafts and implants placed 




Materials and methods 
Study design 
The present study was designed as a case-control study. Prior to the start of the investigation, 
ethical approval was obtained (KEK-ZH-Nr. 2013-0429).  
The electronic database of the Clinic of Fixed and Removable Prosthodontics and Dental Material 
Science, Center of Dental Medicine, University of Zurich was screened for potentially eligible 
patients having received an autogenous bone block graft between 2001 and 2007 (AB group). For 
the NB group, a pool of patients having received an implant in native bone with a follow-up of at 
least 5 years after implant placement was available. Nineteen patients per group were randomly 
selected for the follow-up examination. All patients included were asked to sign an informed 
consent. The follow-up visits took place between the January 2014 and June 2015. Patients 
unwilling to attend a follow-up examination and pregnant patients were excluded from the study. 
Altogether, 27 implants were placed in 19 patients in the test group and 40 implants were placed 
in 19 patients in the control group. All 67 placed implants were included in the statistical analysis. 
Chart review 
A chart review of the patients’ history was performed. This included: demographic data (gender, 
age, smoking status), the date of surgery, the location of the receipt site (if applicable), materials 
used for bone augmentation (if applicable), the general wound healing after bone augmentation 
(if applicable), the time between the grafting procedure (if applicable) and implant placement, and 
if described any reported complications, the respective severity and if the therapy of these 




Intraoral radiographs were taken using a paralleling technique with Rinn-holders (Super-Bite™, 
Kerr, Bioggio, Switzerland) and digital films. As the primary outcome, mesial and distal marginal 
bone levels (MBL) were calculated using an open-source software (Image J, National Institutes of 
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Health, Bethesda, Maryland USA). The radiographic distance between two implant threads was 
used to normalize for the magnification factor. The MBL was determined as the distance between 
the implant reference points (flat top of two-piece implants; implant shoulder minus 1.8mm for 
one-piece implants (this represents the transition between rough and smooth surface) and the first 
bone to implant contact (Gamper et al., 2017). Thereby, smaller values represent higher bone 
levels, i.e. the marginal bone level is closer to the implant shoulder (more favorable). All 
measurements were performed by the same blinded examiner not involved in any of the surgical 
and/or prosthetic procedures.  
 
Clinical examination 
As secondary parameters, the survival of the implants and general periodontal parameters were 
assessed including the two neighboring teeth. Recorded measurements were probing depth (PD) 
(Ramfjord, 1974), plaque control record (PCR) (O'Leary et al., 1972) bleeding on probing (BOP) 
(Ainamo and Bay, 1975), recession (REC) and the buccal width of the keratinized tissue (KT). All 
measurements except KT were recorded at 6 sites per tooth and implant (mesiobuccal, buccal, 
distobuccal, distolingual, lingual and mesiolingual) using a UNC-15 periodontal probe (Hu-Friedy, 
Chicago, IL, USA). The width of the KT was measured at the buccal aspect of all implants.  
Additionally, general dental findings (sensitivity testing, sensation problems, changes of the 
morphology and the presence or absence of teeth) were recorded at sites adjacent to the implants 





In order to assess patient-reported outcome measures (PROMs) regarding the donor/recipient 
site, a questionnaire with six specific questions was filled out by the patients. Question one and 
two related to any sensory problems (change over time) and adverse symptoms at the donor 
site. Question three related to adverse symptoms at the recipient site. Questions four to six were 
asked using a VAS (visual analog scale) ranging from 1 to 10. Question 4 related to the 
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perception of the surgical intervention. With question 5, patients were asked whether or not they 
would undergo the surgery for a second time. Question 6 asked whether or not patients would 
recommend the therapy to a family member.  
 
NB group 
A slightly modified questionnaire was handed to the patients in the NB group. The first two 
questions were excluded since no donor site was apparent in the NB group. 
 
Statistical analysis 
The sample size was calculated for parametric testing (Unpaired t-test) using the following link: 
http://biomath.info/power/ttest.htm. The assumptions for the primary outcome (radiographic 
marginal bone level changes) were 2 mm for the AB group, 1 mm for the NB group with a 
standard deviation of 1 mm (Dasmah et al., 2012). The computed sample size was 17 patients 
per group. A priori sample size calculation can only be performed for parametric testing, we were 
however expecting to obtain non-normally distributed data. To compensate we added 15% to 
obtain a final sample size of 19 per group.  
All data were recorded in Microsoft Excel spreadsheets (Microsoft Corporation, Redmond, WA, 
USA). Statistical analysis was performed with SAS Version 9.4. The data was analyzed 
descriptively, and p-values were calculated using nonparametric mixed models to account for the 





Demographics and survival 
Overall 38 subjects participated in the follow-up examination split in equally sized NB and AB 
groups with 19 patients (Table 1). The patients’ age range was 30 to 92 years. The patients in the 
AB group had a mean age of 50 years (range: 30 – 76) and in the NB group of 72 years (57 – 92). 
Smoking habits were reported in the AB group only (two patients 5<10 cigarettes per day (Table 
1)). There were no heavy smokers (>10cig/day) included in the study. According to Nitzan et al. 
(Nitzan et al., 2005) smoking as a strong confounding factor is therefore excluded. 
Recipient site locations are displayed in Table 2. All autogenous bone blocks were applied in 
combination with a xenogeneic bone substitute material (Bio-Oss, Geistlich Biomaterials) and a 
xenogeneic native collagen membrane (Bio-Gide, Geistlich Biomaterials). Dental implants were 
placed after a mean healing time of 7 months (range 5-12 months). 
The mean follow-up time after implant placement was 10 years (range 6-13 years) in the AB and 
9 years (range 5-16 years) in the NB group. 
The overall implant survival rate was 98.5%. One implant was lost in the NB group due to peri-
implant disease (position 13). Hence, the survival rate for the AB group was 100% and for the NB 
group 97.5% 
Chart review 
Complications following primary augmentation (AB group only) 
In six patients, complications were observed at the donor sites, but none at the receipt sites. The 
complications at the donor site were considered to be major (two wound dehiscences, one case 
with an acute pulpitis of three teeth, two sensitivity disturbances (extraorally decreased 
sensitivity) and one wound dehiscence combined with sensitivity disturbance (extraorally 
decreased sensitivity). One tooth with a pulpitis (in position 41) had to undergo root canal 
treatment. One patient had a sensitivity disturbance that slightly improved over time. All other 
complications were successfully treated (wound dehiscences) or healed without further therapy.  
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Complications following implant placement (AB and NB group) 
No patients in the AB group reported complications after implant placement. In the NB group, 
two complications reported in two patients were considered as being minor (one inflammation 
and one swelling). Both complications healed thereafter without further therapy. 
 
Follow-up examination and outcomes 
Radiographic marginal bone levels 
The median marginal bone level (distance between implant reference points and the first bone to 
implant contact) at the follow-up was 1.58 mm (Q1: 1.01 mm/Q3: 2.40 mm) in the AB group 
and 1.15 mm (0.50 mm/1.83 mm) in the NB group. This difference was statistically significant 
(p=0.0411). (Table 3). 
Clinical parameters 
Median PD values of the implants were 2.83 mm (Q1:2.50 mm/Q3:3.83 mm) in the AB group 
and 2.83 mm (Q1:2.67 mm/Q3:3.33 mm) in the NB group (Table 3). Median BOP [%] values of 
the implants were 0 (Q1:0/Q3:16.67) in the AB group and 0 (Q1:0/Q3:16.67) in the NB group 
(Table 3). Median PCR [%] values of the implants were 0 (Q1:0/Q3:16.67) in the AB group and 0 
(Q1:0/Q3:0) in the NB group (Table 3). The median width of keratinized tissue of the implants 
was 3 mm (Q1:2 mm/Q3:4 mm) in the AB and 3 mm (Q1:1.25 mm/Q3:4 mm) in the NB group 
(Table 3). The median recession of the implants was 0 mm (0 mm/0.5 mm) in the AB and 0 mm 
(0 mm/0 mm) in the NB group (p=0.0503) (Table 3). There were no statistically significant 
differences between the groups. 
 
Patient-reported outcome measures (PROMs) based on questionnaires 
After primary augmentation (AB group) 
Seven patients described an extraoral skin sensitivity after surgery at the donor site. In three 
sites, the skin sensitivity was still present at the follow-up. Moreover, three patients described 
intraoral sensitivity at the donor site being present at the follow-up examination. 
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Implant placement (both groups) 
Five subjects in the AB group and five subjects in the NB group reported sensitivity at the 
implant site at the follow-up. 
Evaluation of the surgical intervention (bone augmentation and implant placement in the AB, 
implant placement in the NB group) using a VAS 
Median VAS for the overall rating of the surgical interventions were 9 (8/10) in the AB and 10 
(8.5/10) in the NB group (Figure 1). The two other questions regarding the repetition of the 
surgical intervention was answered with similarly high VAS ratings (median VAS = 10; range 
between 5.5 to 10 (AB) and 7 to 10 (NB)). This was in line with patients recommending the 
surgical intervention of primary bone augmentation (median 10) and of implant placement in the 
NB group (10) to a family member.  
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Discussion 
The present study assessing outcomes of implant therapy in sites with primary bone 
augmentation (AB) and sites with implant placement into native bone (NB) revealed: i) high 
implant survival rates independent of a primary bone augmentation procedure; ii) a higher 
marginal bone level in group NB compared to group AB; iii) 37% of patients with complications 
following the primary augmentation (group AB) and 16% of patients (groups NB and AB) with 
complications still present at the follow-up and, iv) a high satisfaction rate with implant therapy 
based on VAS questionnaires. 
Both treatment modalities resulted in favorable clinical outcomes at a mean follow-up of 10 
years. These results are in line with the literature (Raghoebar et al., 2007, Al-Nawas and 
Schiegnitz, 2014). In addition, the low rate of implant loss is in accordance with a recent meta-
analysis (Moraschini et al., 2015) investigating the long-term success rates of dental implants. 
Although one implant was lost in the NB group due to peri-implant disease, no significant 
difference was observed between the two groups. Scientific evidence on dental implants placed 
in autogenous bone blocks and long-term follow-up data are scarce. According to clinical studies 
with 5-year, 10-year and 12-year follow-up examinations, the survival rate of implants placed in 
primarily augmented autogenous bone is high and similar to the present investigation (Keller et 
al., 1999) (Gulinelli et al., 2017) (Chappuis et al., 2017). Moreover, the survival rates are high 
and comparable to implants placed in native bone (Buser et al., 2002, Levin et al., 2007), which 
is, again, in line with the present study. 
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Apart from survival rates, marginal bone levels are a suitable tool to analyse the stability of the 
augmented or native bone surrounding dental implants. In the present study, a significantly 
lower marginal bone level was observed for implants placed in previously augmented bone 
compared to implants placed in pristine bone (higher MBL values). Marginal bone level(s) 
changes at implants placed in augmented autogenous bone blocks are relatively consistent 
(Galindo-Moreno et al., 2015, Johansson et al., 2001, Barone and Covani, 2007). In a clinical 
study with 68 implants and a 10-year follow-up, the treatment with intraoral autogenous bone 
blocks was considered to be successful, reporting a very limited marginal bone loss (0.6mm) 
over time (Roccuzzo et al., 2016). Absolute marginal bone levels, however, were not reported. 
Similar changes over time (up to 5 years) of 0.7mm were observed in a clinical study using 
autogenous bone grafts from the iliac crest. The marginal bone levels were similar to the present 
study, though, being located 2.0 to 2.3mm below the reference level (Dasmah et al., 2012). In 
the absence of data, comparing marginal bone levels at implant sites with or without primary 
bone augmentation, one might speculate on the reason for the observation of a significantly 
lower first bone to implant contact group AB in the present study. According to a histological 
study, the majority of the osteocytes of an autogenous transplant appeared not to survive and 
neovascularization was suggested to be often difficult (Acocella et al., 2010). Moreover, 
depending on the quality of the bone, altered resorption rates were reported (Spin-Neto et al., 
2015). As such, a higher resorption of transplanted autogenous bone could at least in part 
explain the observed differences between NB and AB implants. This is supported by a clinical  
study, analyzing cone-beam computed tomographic data after block augmentation, 
demonstrating a mean volume resorption of 35–51% (Sbordone et al., 2009). Volumetric and 
linear changes of the augmented bone blocks were, however, not assessed in the present 
investigation. It has to be noted that additional to the block grafts, xenogenic bone particulate 
was used to fill up the spaces. According to (Hallman et al., 2001, Meloni et al., 2017) the use of 
xenogenic bone usually results in slower resorption rates. This stands in contrast to our results 
since we see a higher resorption rate in this group. The effect can be explained by the fact that 
only a minimum amount of xenogenic bone has been used during the surgery. 
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Moreover, the data suggest that both treatments perform well in terms of clinical outcome 
measures, such as PD, BOP, PCR and KT. This was underlined by both procedures resulting in 
long-term stable peri-implant tissues, even though on the level of the bone, differences exist. 
This is also in line with previous reports on the long-term outcomes of implant therapy with 
simultaneous guided bone regeneration and the observation that even in case of a lack of buccal 
bone, the soft tissues remained clinically stable to a high extent (Benic et al., 2012, Kuchler et 
al., 2016).  
As expected, the surgical intervention of augmenting bone resulted in a relatively high 
complication rate of 37%. Various complications were observed subsequently including extra- 
and intraoral sensitivity, devitalization of neighbouring teeth and wound dehiscences at the 
donor site. Based on a systematic review (Nkenke and Neukam, 2014), patient’s acceptance for 
chin bone harvesting was generally low due to pain and skin sensitivity. At the follow-up 
examination, the majority of the observed complications were not present anymore based on the 
present study. Interestingly, analysing patients’ questionnaires, patient morbidity, even though 
being high immediately following surgery, appears to be transient. The overall rating of the 
procedure, the willingness to repeat the procedure and the likelihood to recommend the 
procedure were overall high and demonstrated no differences between the groups. These results 
have to be interpreted with some caution due to the retrospective study design and a, from a 
patients’ point of view, biased participation in the follow-up examination. Moreover, the study 
should have been designed as a matched case-control study. The baseline characteristics of the 






Dental implants placed in sites augmented with autogenous bone or in native bone revealed 
healthy peri-implant tissues after 5-16 years. Marginal bone levels were significantly higher for 
implant placed in native bone. Complications following primary augmentation encompassed every 
third patient, but were mostly transient and did not affect long-term patient-reported outcome 
measures.  
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Figure legends  
Table 1: Demographics and survival rates at 5-16 years 
STM=Straumann Implant; BRA= Brånemark System; AB=autogenous block; NB=native bone 
Table 2: Implant position 
Implant positions and implant types are plotted in a tooth scheme; STM=Straumann Implant; 
BRA= Brånemark System Mk III TiUnite; AB=autogenous block; NB=native bone 
Table 3: Radiographic and clinical parameters of implants at 5-16 years 
Clinical measurements are plotted as median values with lower (Q1) and upper (Q3) quartile and 
means with standard deviations (SD). The p-values were calculated using mixed models for 
nonparametric testing (Brunner-Langer Analysis); STM=Straumann Implant; BRA= Brånemark 
System; AB=autogenous block; NB=native bone; PD=probing depth; BOP=bleeding on probing; 
PCR=plaque control record; KT=width of keratinized tissue; REC=buccal recession. 
Figure 1: Patient related outcome measures at 5-16 years 
Data from VAS are plotted as single values; Median values are shown as lines; Test=autogenous 
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Table 1  
    Total AB NB 
Age [years]   62.8 51.9 71.1 
Gender female 20 6 14 




2 2 0 
 
Heavy smoker (>10 
cig/day) 
0 0 0 
 non-smoker 36 17 19 
Follow-up time [years]   9.1 10.2 8.3 
Number of implants  67 19 40 
Implant type STM 25 13 12 
 BRA 42 14 28 
Survival number of implants 66 19 39 
  % 98.5 100.0 97.5 
 
 
Table 2  
 
Site   17 16 15 14 13 12 11 21 22 23 24 25 26 
AB STM 0 0 0 0 1 3 3 1 2 1 0 0 0 
  BRA 0 0 0 1 1 4 3 1 1 2 0 0 0 
NB STM 0 0 1 0 1 3 0 2 2 1 1 0 0 
  BRA 0 3 2 3 2 0 2 0 2 0 2 2 1 
AB STM 0 0 0 0 0 0 1 1 0 0 0 0 0 
  BRA 0 0 0 0 0 0 0 1 0 0 0 0 0 
NB STM 0 1 0 0 0 0 0 0 0 0 0 0 0 
  BRA 1 1 1 0 1 0 0 0 0 1 1 1 2 
Site   47 46 45 44 43 42 41 31 32 33 34 35 36 
  
Table 3  
 
Variable Group N Mean  Std Min Q1 Median Q3 Max p-value 
Marginal bone level 
[mm] 
NB 40 1.21 0.93 0.00 0.50 1.15 1.83 3.04  
AB 27 1.75 1.11 0.09 1.01 1.58 2.40 4.33 0.0411 
PD 
NB 40 3.01 0.63 1.17 2.67 2.83 3.33 4.33  
AB 27 3.13 0.70 2.17 2.50 2.83 3.83 4.67 0.9954 
BOP [%] 
NB 40 7.08 10.60 0.00 0.00 0.00 16.67 33.33  
AB 27 9.88 11.56 0.00 0.00 0.00 16.67 33.33 0.5602 
PCR [%] 
NB 40 4.17 8.23 0.00 0.00 0.00 0.00 33.33  
AB 27 11.11 17.90 0.00 0.00 0.00 16.67 50.00 0.2673 
KT 
NB 40 2.69 1.51 0.00 1.25 3.00 4.00 6.00  
AB 27 2.91 1.09 0.00 2.00 3.00 4.00 5.00 0.0454 
REC 
NB 40 0.17 0.46 0.00 0.00 0.00 0.00 2.50  
AB 27 0.38 0.57 0.00 0.00 0.00 0.50 2.00 0.0503 
  
